|drug1605||In-person postoperative visit Wiki||1.00|
|drug2903||SARS-Cov-2 infection Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The purpose of this clinical study is to evaluate whether remote video/audio postoperative visits (telemedicine visits) affects patient satisfaction compared to in-person visits during the COVID-19 pandemic. If the primary objective of the study is achieved, it would allow better understanding of how telemedicine can be integrated into modern surgical practice to take care of postoperative patients.
Description: Patient satisfaction score measured by electronic survey sent to all participating patients after their first postoperative visitMeasure: Patient satisfaction Time: 7 to 14 days postoperatively
Description: Patient-reported safety score rated from 1 to 5Measure: Safety score Time: 7 to 14 days postoperatively
Description: Length of postoperative visitMeasure: Length of visit Time: 7 to 14 days postoperatively
Description: Patient willingness to recommend provider to peers rated from 1 to 5Measure: Patient willingness to recommend provider to peers rated from 1 to 5 Time: 7 to 14 days postoperatively
Description: Combined patient satisfaction score from 1st and 2nd postoperative visitsMeasure: Combined patient satisfaction score from 1st and 2nd postoperative visits Time: 7 to 31 days postoperatively
Description: Distance (in kilometers) of patient's primary residence to the clinic locationMeasure: Distance (in kilometers) of patient's primary residence to the clinic location Time: 7 to 31 days postoperatively
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports